1. Home
  2. ZLAB vs CABO Comparison

ZLAB vs CABO Comparison

Compare ZLAB & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CABO
  • Stock Information
  • Founded
  • ZLAB 2013
  • CABO 1980
  • Country
  • ZLAB China
  • CABO United States
  • Employees
  • ZLAB N/A
  • CABO N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CABO Cable & Other Pay Television Services
  • Sector
  • ZLAB Health Care
  • CABO Telecommunications
  • Exchange
  • ZLAB Nasdaq
  • CABO Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CABO 717.5M
  • IPO Year
  • ZLAB 2017
  • CABO N/A
  • Fundamental
  • Price
  • ZLAB $35.19
  • CABO $121.02
  • Analyst Decision
  • ZLAB Buy
  • CABO Hold
  • Analyst Count
  • ZLAB 5
  • CABO 3
  • Target Price
  • ZLAB $54.28
  • CABO $231.00
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • CABO 199.9K
  • Earning Date
  • ZLAB 08-07-2025
  • CABO 07-31-2025
  • Dividend Yield
  • ZLAB N/A
  • CABO 7.36%
  • EPS Growth
  • ZLAB N/A
  • CABO N/A
  • EPS
  • ZLAB N/A
  • CABO N/A
  • Revenue
  • ZLAB $418,326,000.00
  • CABO $1,555,831,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CABO N/A
  • Revenue Next Year
  • ZLAB $49.13
  • CABO N/A
  • P/E Ratio
  • ZLAB N/A
  • CABO N/A
  • Revenue Growth
  • ZLAB 43.72
  • CABO N/A
  • 52 Week Low
  • ZLAB $16.01
  • CABO $119.54
  • 52 Week High
  • ZLAB $44.34
  • CABO $437.00
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • CABO 35.51
  • Support Level
  • ZLAB $32.31
  • CABO $126.35
  • Resistance Level
  • ZLAB $35.72
  • CABO $137.88
  • Average True Range (ATR)
  • ZLAB 1.10
  • CABO 6.13
  • MACD
  • ZLAB -0.34
  • CABO 0.69
  • Stochastic Oscillator
  • ZLAB 60.17
  • CABO 2.34

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

Share on Social Networks: